Beat In-Albon
Director/Board Member at EVOLVA HOLDING SA
Net worth: 483 294 $ as of 2024-05-30
Network origin in Beat In-Albon first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Fribourg
20
| College/University | Other Consumer Services | 20 |
| Public Company | Biotechnology | 20 | |
| Public Company | Food: Specialty/Candy | 18 | |
12
| Public Company | Miscellaneous Commercial Services | 12 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland.
10
| Subsidiary | Biotechnology | 10 |
| Public Company | Pharmaceuticals: Major | 6 | |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden.
5
| Subsidiary | Financial Conglomerates | 5 |
Deccan Fine Chemicals (India) Pvt Ltd.
 Deccan Fine Chemicals (India) Pvt Ltd. Chemicals: SpecialtyProcess Industries Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India.
4
| Private Company | Chemicals: Specialty | 4 |
| Public Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Beat In-Albon via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Swiss Federal Institute of Technology | College/University | Graduate Degree President Doctorate Degree Corporate Officer/Principal Graduate Degree Masters Business Admin Doctorate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Zurich | College/University | Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree | |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chemicals: Specialty | Chief Executive Officer Director/Board Member Chief Executive Officer Chairman Corporate Officer/Principal | |
| VON ROLL HOLDING | Electrical Products | Chief Executive Officer Chairman Director of Finance/CFO | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of Bern | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
PrivatAir SA
 PrivatAir SA AirlinesTransportation PrivatAir SA provides airline, ground, sales, and management services. Its services include private charter, airline, ground, aircraft sales, and management services. The company was founded in 1977 and is headquartered Geneva, Switzerland. | Airlines | Chairman Chairman | |
Cushman & Wakefield, Inc.
 Cushman & Wakefield, Inc. Real Estate DevelopmentFinance Cushman & Wakefield, Inc. provides commercial real estate services. Its services include agency leasing, asset services, capital markets, facility services, global occupier services, investment and asset management, project and development, tenant representation, and valuation and advisory. The company was founded by J. Clydesdale Cushman and Bernard Wakefield on October 31, 1917 and is headquartered in New York, NY. | Real Estate Development | Chairman Corporate Officer/Principal | |
C&W Group, Inc.
 C&W Group, Inc. Real Estate DevelopmentFinance C&W Group, Inc. operates as a holding company which through its subsidiary provides commercial real estate brokerage and consultancy services. The company is headquartered in New York, NY. | Real Estate Development | Chairman Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEQUANA | Wholesale Distributors | Chief Executive Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree | |
Polypeptide Laboratories France SAS
 Polypeptide Laboratories France SAS Chemicals: SpecialtyProcess Industries Part of PolyPeptide Group AG, Polypeptide Laboratories France SAS is a contract manufacturer of organic peptides. The company is based in Strasbourg, France. | Chemicals: Specialty | Chairman Chief Executive Officer | |
| UBS | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | President Undergraduate Degree | |
| Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
Niederer Kraft Frey AG
 Niederer Kraft Frey AG Miscellaneous Commercial ServicesCommercial Services Niederer Kraft Frey AG operates as a full-service Swiss law firm. The company provides legal services. It specializes in strategic goals implementation and strengthening of business. The company was founded in 1936 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
Helvetia Insurance Switzerland
 Helvetia Insurance Switzerland Insurance Brokers/ServicesFinance Part of Helvetia Holding AG, Helvetia Insurance Switzerland is a Swiss insurance company. The company is based in St. Gallen, Switzerland. The CEO of the company is Martin Jara. | Insurance Brokers/Services | Director/Board Member Chief Executive Officer | |
| Technical University of Denmark | College/University | Doctorate Degree Doctorate Degree | |
| BVZ HOLDING AG | Railroads | Chief Executive Officer Chief Executive Officer | |
| Drexel University | College/University | Masters Business Admin Undergraduate Degree | |
| HELVETIA HOLDING AG | Multi-Line Insurance | Director/Board Member Chief Executive Officer | |
| Swiss Insurance Association | Corporate Officer/Principal Director/Board Member | ||
Zurich Chamber of Commerce
 Zurich Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Zurich Chamber of Commerce is a business organization that serves as a platform for companies to connect and collaborate. The Chamber of Commerce is based in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SIKA AG | Chemicals: Major Diversified | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Matterhorn Gotthard Bahn AG
 Matterhorn Gotthard Bahn AG RailroadsTransportation Matterhorn Gotthard Bahn AG operates as a narrow gauge railway line and a railway company. It offers bike and rail, adventure card, oberalp openair express and hiking. The company is headquartered in Brig, Switzerland. | Railroads | Chief Executive Officer Chief Executive Officer | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
Matterhorn Gotthard Verkehrs AG
 Matterhorn Gotthard Verkehrs AG RailroadsTransportation Matterhorn Gotthard Verkehrs AG engages in the management and operation of railways, which include rolling stock, warehouse, and repair shops. Its business activities focus on the management of passenger, goods, and car transport as well as the maintenance, refurbishment, and procurement of rolling stock. The company was founded in 1889 and is headquartered in Brig, Switzerland. | Railroads | Director/Board Member Director/Board Member | |
| Personalvorsorgestiftung Matterhorn Gotthard Bahn | Director/Board Member Director/Board Member | ||
| RAILPlus AG | Director/Board Member Director/Board Member | ||
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| Verband Öffentlicher Verkehr | Corporate Officer/Principal Corporate Officer/Principal | ||
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| Lucerne University of Applied Sciences & Arts | College/University | Graduate Degree Graduate Degree | |
| GE AEROSPACE | Industrial Machinery | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Medical/Nursing Services | Director/Board Member Director/Board Member |
Statistics
International
| Switzerland | 27 |
| United States | 9 |
| Denmark | 5 |
| United Kingdom | 5 |
| Italy | 4 |
Sectoral
| Consumer Services | 15 |
| Finance | 10 |
| Health Technology | 6 |
| Producer Manufacturing | 5 |
| Transportation | 5 |
Operational
| Director/Board Member | 396 |
| Corporate Officer/Principal | 189 |
| Chairman | 127 |
| Chief Executive Officer | 87 |
| Graduate Degree | 49 |
Most connected contacts
| Insiders | |
|---|---|
| Pascal Lebard | 42 |
| John Jacob Philip Elkann | 39 |
| Patrick Aebischer | 35 |
| Thomas Staehelin | 32 |
| Reto A. Garzetti | 30 |
| Ivo Furrer | 29 |
| Christoph Caviezel | 28 |
| Petros Kalantzis | 27 |
| Carlo Barel di Sant’Albano | 21 |
| Philipp Robert Gmür | 19 |
| Richard Tobin | 19 |
| Hans-Rudolf Mooser | 19 |
| Romeo Cerutti | 18 |
| Dorothée Anna Deuring | 18 |
| Gerhard Mayr | 18 |
- Stock Market
- Insiders
- Beat In-Albon
- Company connections
